Hologic, Inc. (0J5Q.L)
USD 58.82
(-2.44%)
USD 58.82
(-2.44%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 2.49 Billion USD | -1.35% |
| 2023 | 2.53 Billion USD | -9.87% |
| 2022 | 2.8 Billion USD | 3.55% |
| 2021 | 2.71 Billion USD | -0.06% |
| 2020 | 2.71 Billion USD | -2.5% |
| 2019 | 2.78 Billion USD | 2.92% |
| 2018 | 2.7 Billion USD | 24.52% |
| 2017 | 2.17 Billion USD | -28.77% |
| 2016 | 3.04 Billion USD | -6.32% |
| 2015 | 3.25 Billion USD | -22.26% |
| 2014 | 4.18 Billion USD | -2.07% |
| 2013 | 4.27 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 2.5 Billion USD | -0.34% |
| 2024 Q2 | 2.51 Billion USD | -0.34% |
| 2024 Q1 | 2.52 Billion USD | -0.34% |
| 2024 Q4 | 2.49 Billion USD | -0.34% |
| 2023 Q3 | 2.78 Billion USD | -0.3% |
| 2023 Q4 | 2.53 Billion USD | -9.25% |
| 2023 FY | 2.53 Billion USD | -9.87% |
| 2023 Q1 | 2.8 Billion USD | -0.08% |
| 2023 Q2 | 2.79 Billion USD | -0.3% |
| 2022 Q1 | 2.81 Billion USD | 3.96% |
| 2022 FY | 2.8 Billion USD | 3.55% |
| 2022 Q4 | 2.8 Billion USD | -0.22% |
| 2022 Q3 | 2.81 Billion USD | 0.04% |
| 2022 Q2 | 2.81 Billion USD | -0.22% |
| 2021 Q1 | 2.72 Billion USD | -3.33% |
| 2021 Q3 | 2.65 Billion USD | -2.03% |
| 2021 Q4 | 2.71 Billion USD | 2.17% |
| 2021 FY | 2.71 Billion USD | -0.06% |
| 2021 Q2 | 2.7 Billion USD | -0.6% |
| 2020 Q3 | 2.84 Billion USD | -0.55% |
| 2020 Q4 | 2.81 Billion USD | -0.75% |
| 2020 FY | 2.71 Billion USD | -2.5% |
| 2020 Q1 | 2.86 Billion USD | 0.85% |
| 2020 Q2 | 2.85 Billion USD | -0.13% |
| 2019 Q3 | 2.81 Billion USD | -0.3% |
| 2019 FY | 2.78 Billion USD | 2.92% |
| 2019 Q4 | 2.83 Billion USD | 0.9% |
| 2019 Q2 | 2.81 Billion USD | -0.3% |
| 2019 Q1 | 2.82 Billion USD | 2.44% |
| 2018 FY | 2.7 Billion USD | 24.52% |
| 2018 Q3 | 2.74 Billion USD | -0.64% |
| 2018 Q4 | 2.76 Billion USD | 0.65% |
| 2018 Q1 | 2.78 Billion USD | 24.73% |
| 2018 Q2 | 2.76 Billion USD | -0.68% |
| 2017 FY | 2.17 Billion USD | -28.77% |
| 2017 Q1 | 2.61 Billion USD | -15.19% |
| 2017 Q2 | 2.25 Billion USD | -13.69% |
| 2017 Q3 | 2.23 Billion USD | -1.18% |
| 2017 Q4 | 2.22 Billion USD | -0.09% |
| 2016 FY | 3.04 Billion USD | -6.32% |
| 2016 Q4 | 3.08 Billion USD | -0.15% |
| 2016 Q3 | 3.08 Billion USD | -0.3% |
| 2016 Q2 | 3.09 Billion USD | -4.36% |
| 2016 Q1 | 3.23 Billion USD | -0.49% |
| 2015 FY | 3.25 Billion USD | -22.26% |
| 2015 Q4 | 3.25 Billion USD | -0.48% |
| 2015 Q3 | 3.27 Billion USD | -2.6% |
| 2015 Q2 | 3.35 Billion USD | -11.99% |
| 2015 Q1 | 3.81 Billion USD | -8.88% |
| 2014 FY | 4.18 Billion USD | -2.07% |
| 2014 Q4 | 4.18 Billion USD | 0.45% |
| 2014 Q3 | 4.16 Billion USD | -0.37% |
| 2014 Q2 | 4.18 Billion USD | -0.97% |
| 2014 Q1 | 4.22 Billion USD | -1.19% |
| 2013 Q4 | 4.27 Billion USD | -1.65% |
| 2013 Q3 | 4.34 Billion USD | -4.48% |
| 2013 Q2 | 4.55 Billion USD | 7.41% |
| 2013 Q1 | 4.23 Billion USD | 0.0% |
| 2013 FY | 4.27 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -121769.204% |
| Accuray Incorporated | 164.4 Million USD | -1418.917% |
| Align Technology, Inc. | 96.96 Million USD | -2475.179% |
| Elevance Health Inc. | 23.24 Billion USD | 89.258% |
| AxoGen, Inc. | 46.6 Million USD | -5258.239% |
| Boston Scientific Corporation | 8.56 Billion USD | 70.849% |
| CVS Health Corporation | 74.67 Billion USD | 96.656% |
| Cardinal Health, Inc. | 4.58 Billion USD | 45.514% |
| Centene Corporation | 17.69 Billion USD | 85.891% |
| DaVita Inc. | 8.05 Billion USD | 68.985% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 93.183% |
| Humana Inc. | 10.21 Billion USD | 75.55% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -300.894% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 38.415% |
| Masimo Corporation | 871.7 Million USD | -186.463% |
| McKesson Corporation | 5.45 Billion USD | 54.19% |
| Patterson Companies, Inc. | 328.91 Million USD | -659.202% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 43.376% |
| ResMed Inc. | 697.31 Million USD | -258.103% |
| Henry Schein, Inc. | 1.93 Billion USD | -29.183% |
| Teladoc Health, Inc. | 1.58 Billion USD | -57.892% |
| Universal Health Services, Inc. | 4.71 Billion USD | 47.052% |
| Veeva Systems Inc. | 46.44 Million USD | -5276.93% |
| Baxter International Inc. | 11.06 Billion USD | 77.43% |
| Becton, Dickinson and Company | 14.73 Billion USD | 83.057% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 3141.535% |
| Danaher Corporation | 17.66 Billion USD | 85.861% |
| Stryker Corporation | 10.9 Billion USD | 77.093% |
| Medtronic plc | 23.87 Billion USD | 89.542% |